Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Kromek Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Kromek Group şirketinin toplam hissedar öz sermayesi £47.3M ve toplam borcu £8.9M olup, bu da borç-öz sermaye oranını 18.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £68.7M ve £21.4M dir.

Anahtar bilgiler

18.8%

Borç/özkaynak oranı

UK£8.90m

Borç

Faiz karşılama oranı	n/a
Nakit	UK£3.72m
Eşitlik	UK£47.31m
Toplam yükümlülükler	UK£21.43m
Toplam varlıklar	UK£68.75m

Son finansal sağlık güncellemeleri

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Aug 04

Recent updates

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Apr 20

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Sep 02

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

Jan 14

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: KMK 'nin kısa vadeli varlıkları ( £22.0M ) kısa vadeli yükümlülüklerini ( £10.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: KMK şirketinin kısa vadeli varlıkları ( £22.0M ) uzun vadeli yükümlülüklerini ( £10.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: KMK 'nin net borç/öz sermaye oranı ( 11% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: KMK şirketinin borç/öz sermaye oranı son 5 yılda 13.6% seviyesinden 18.8% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: KMK şirketinin mevcut serbest nakit akışına dayanarak yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Tahmini Nakit Akışı: KMK tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Kromek Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Recent updates

Price target increased by 9.8% to UK£0.28

New minor risk - Financial data availability

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Kromek Group plc (LON:KMK) Soars 46% But It's A Story Of Risk Vs Reward

Kromek Group plc, Annual General Meeting, Mar 04, 2024

Kromek Group plc Grants £1.3 Million Under Horizon Europe Guarant Scheme New Joint Project to Develop AI-Powered Radiation Sensor Powered by Artificial Intelligence

First half 2024 earnings released: UK£0.005 loss per share (vs UK£0.012 loss in 1H 2023)

Kromek Group plc to Report First Half, 2024 Results on Jan 30, 2024

New minor risk - Financial data availability

Kromek Group plc's (LON:KMK) Price In Tune With Revenues

Kromek Group plc, Annual General Meeting, Sep 28, 2023

Kromek Group plc Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £1.028219 million.

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £7 million.

Kromek Group plc's (LON:KMK) Revenues Are Not Doing Enough For Some Investors

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.005 loss in 1H 2022)

Price target decreased to UK£0.27

Less than half of directors are independent

Kromek Group plc, Annual General Meeting, Sep 28, 2022

Kromek Group plc announced that it has received £1.14 million in funding

Kromek Group plc announced that it has received £1.7 million in funding

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Full year 2022 earnings: EPS misses analyst expectations

Kromek Group plc Provides Earnings Outlook for the Year Ended 30 April 2022

Price target decreased to UK£0.38

Less than half of directors are independent

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Kromek Group plc Provide Earnings Guidance for the Year Ended April 30, 2021

Kromek Group plc Awards Nuclear Detection Contract

Kromek Wins Medical Screening and Nuclear Security Orders

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £10 million.

New 90-day high: UK£0.20

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

First half 2021 earnings released: UK£0.009 loss per share

Kromek Group plc Announces Funding to Advance Bio-Threat Detection Solution

Kromek Group plc Announces Management Changes

Kromek Group plc to Report First Half, 2021 Results on Jan 13, 2021

Kromek Group plc Launches the D5 RIID Radiation Detector

Rmd’S Cllbc Technology Successfully Integrated in Kromek’S Riid

Kromek Group plc Commences Development of A New System to Improve the Pathological Medical Imaging Techniques Used During Cancer Surgery

Full year earnings released

Annual earnings released: Revenue misses expectations

Kromek Group plc Appoints Rakesh Sharma Obe as A Non-Executive Director

Kromek Launches the D3 PRD High-Accuracy Personal Radiation Detector

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin